TCL Archive NCI Funding Plan For 1983: 20% Cut From Recommended Levels for All Grants, Change In Program Projects October 8, 1982
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005